These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32545461)

  • 1. Low-Dose Aspirin Use Significantly Improves the Survival of Late-stage NPC: A Propensity Score-Matched Cohort Study in Taiwan.
    Luo SD; Chen WC; Wu CN; Yang YH; Li SH; Fang FM; Huang TL; Wang YM; Chiu TJ; Wu SC
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545461
    [No Abstract]   [Full Text] [Related]  

  • 2. Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients.
    Pan XX; Liu YJ; Yang W; Chen YF; Tang WB; Li CR
    Laryngoscope; 2020 Mar; 130(3):E83-E88. PubMed ID: 31188486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors of nasopharyngeal carcinoma patients in a tertiary referral hospital: a retrospective cohort study.
    Siti-Azrin AH; Norsa'adah B; Naing NN
    BMC Res Notes; 2017 Dec; 10(1):705. PubMed ID: 29212521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propensity score matching analysis of a phase II study on simultaneous modulated accelerated radiation therapy using helical tomotherapy for nasopharyngeal carcinomas.
    Du L; Zhang XX; Feng LC; Qu BL; Chen J; Yang J; Liu HX; Xu SP; Xie CB; Ma L
    BMC Cancer; 2017 Aug; 17(1):582. PubMed ID: 28851315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of sequential chemoradiotherapy in stage II and low-risk stage III-IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: A propensity score-matched analysis.
    Xu C; Sun R; Tang LL; Chen L; Li WF; Mao YP; Zhou GQ; Guo R; Lin AH; Sun Y; Ma J; Hu WH
    Oral Oncol; 2018 Mar; 78():37-45. PubMed ID: 29496056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic immune-inflammation index predicts the clinical outcome in patients with nasopharyngeal carcinoma: a propensity score-matched analysis.
    Jiang W; Chen Y; Huang J; Xi D; Chen J; Shao Y; Xu G; Ying W; Wei J; Chen J; Ning Z; Gu W; Pei H
    Oncotarget; 2017 Sep; 8(39):66075-66086. PubMed ID: 29029493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma.
    Lan XW; Zou XB; Xiao Y; Tang J; OuYang PY; Su Z; Xie FY
    PLoS One; 2016; 11(8):e0160758. PubMed ID: 27509025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma.
    Lee CC; Chu ST; Chou P; Lee CC; Chen LF
    Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
    Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
    Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of local tumor excision and pharyngectomy on the survival of nasopharyngeal carcinoma patients: a retrospective observational study based on SEER database.
    Sun J; Huang Z; Hu Z; Sun R
    J Transl Med; 2017 May; 15(1):116. PubMed ID: 28558725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of chronic hepatitis B virus infection in patients with nasopharyngeal carcinoma: analysis of 1301 patients from an endemic area in China.
    Liu X; Li X; Jiang N; Lei Y; Tang LL; Chen L; Zhou GQ; Sun Y; Yue D; Guo R; Mao YP; Li WF; Liu LZ; Tian L; Lin AH; Ma J
    Cancer; 2014 Jan; 120(1):68-76. PubMed ID: 24114075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prophylactic irradiation of cervical lymph nodes for Stage-N0 nasopharyngeal carcinoma].
    Xie FY; Peng M; Hu WH; Han F; Wang X; Xu HM
    Chin J Cancer; 2010 Jan; 29(1):106-10. PubMed ID: 20038321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced-Stage Nasopharyngeal Carcinoma: Restaging System after Neoadjuvant Chemotherapy on the Basis of MR Imaging Determines Survival.
    Liu LT; Chen QY; Tang LQ; Zhang L; Guo SS; Xie CM; Liu XW; Guo L; Mo HY; Chen MY; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Bei JX; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
    Radiology; 2017 Jan; 282(1):171-181. PubMed ID: 27479804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The results and prognosis of different treatment modalities for solitary metastatic lung tumor from nasopharyngeal carcinoma: a retrospective study of 105 cases.
    Ma J; Wen ZS; Lin P; Wang X; Xie FY
    Chin J Cancer; 2010 Sep; 29(9):787-95. PubMed ID: 20800020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases: who will benefit from combined treatment?
    Cao X; Han Y; He L; Xiang J; Wen Z
    Oral Oncol; 2011 Aug; 47(8):747-52. PubMed ID: 21665523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of target dosimetry on patients' locoregional recurrence in nasopharyngeal carcinoma: A propensity score-matched analysis.
    Wang J; Qing G; Ou X; Hu W; Hu C; Zhang Z
    Radiother Oncol; 2019 Dec; 141():67-71. PubMed ID: 31547944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NEAT1 is a potential prognostic biomarker for patients with nasopharyngeal carcinoma.
    Liu Z; Wu K; Wu J; Tian D; Chen Y; Yang Z; Wu A
    J Cell Biochem; 2019 Jun; 120(6):9831-9838. PubMed ID: 30618186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced expression of polymeric immunoglobulin receptor (pIgR) in nasopharyngeal carcinoma and its correlation with prognosis.
    Qi X; Li X; Sun X
    Tumour Biol; 2016 Aug; 37(8):11099-104. PubMed ID: 26910773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of a Staging System for Prognosis of 5-Year Survival of Patients With Nasopharyngeal Carcinoma Who Underwent Chemoradiotherapy.
    Huang CI; Chen LF; Chang SL; Wu HC; Ting WC; Yang CC
    JAMA Otolaryngol Head Neck Surg; 2017 Nov; 143(11):1086-1091. PubMed ID: 28975193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of results of treatment for nasopharyngeal carcinoma in Penang General Hospital from 2001-2005.
    Phua CE; Tan BS; Yong TK; Govindasamy M
    Asian Pac J Cancer Prev; 2011; 12(12):3197-200. PubMed ID: 22471453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.